ERIC ROHREN to Antineoplastic Combined Chemotherapy Protocols
This is a "connection" page, showing publications ERIC ROHREN has written about Antineoplastic Combined Chemotherapy Protocols.
Connection Strength
0.141
-
IGF-1R and mTOR Blockade: Novel Resistance Mechanisms and Synergistic Drug Combinations for Ewing Sarcoma. J Natl Cancer Inst. 2016 12; 108(12).
Score: 0.083
-
Phase I trial of cixutumumab combined with temsirolimus in patients with advanced cancer. Clin Cancer Res. 2011 Sep 15; 17(18):6052-60.
Score: 0.058